SunTrust Robinson Humphrey Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $80

SunTrust Robinson Humphrey maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $75 to $80.

Benzinga · 01/10/2020 14:50

SunTrust Robinson Humphrey maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy and raises the price target from $75 to $80.